Retzow A, Emrich H M
Psychiatr Prax. 1998 Jul;25(4):163-71.
This paper gives an overall review of the literature since 1980 on the use of valproate in bipolar affective disorders. Randomised comparative studies definitely demonstrate that valproate proves superior in comparison with placebo and equivalent in comparison with lithium in the treatment of acute manic episodes. A series of open studies indicates a reduction in frequency and intensity of manic and depressive episodes with the long-term administration of valproate suggesting efficaciousness in the prophylaxis of bipolar affective disorders. Details on dosage, side effects and potential interactions with this group of patients are presented. Valproate constitutes a further valuable and well tolerated alternative to lithium, antipsychotic agents and carbamazepine not only in acute therapy of manic episodes but also in prophylactic treatment of patients with bipolar psychosis.
本文对1980年以来有关丙戊酸盐用于双相情感障碍治疗的文献进行了全面综述。随机对照研究明确表明,在治疗急性躁狂发作方面,丙戊酸盐优于安慰剂,且与锂盐等效。一系列开放性研究表明,长期服用丙戊酸盐可降低躁狂和抑郁发作的频率及强度,提示其对双相情感障碍具有预防作用。文中还介绍了该类患者的用药剂量、副作用及潜在相互作用的细节。丙戊酸盐不仅是锂盐、抗精神病药物和卡马西平在急性躁狂发作治疗中的又一有价值且耐受性良好的替代药物,也是双相精神病患者预防性治疗的有效选择。